A retrospective study of treatment outcomes in patients with carcinoma of unknown primary site and a colorectal cancer molecular profile

Clinical Colorectal Cancer

Volumn 11, Issue 2, 2012, Pages 112-118

  Hainsworth, John D ^a,b   Schnabel, Catherine A ^c   Erlander, Mark G ^c   Haines III, David W ^a   Greco, F Anthony ^a,b  

^a SARAH CANNON RESEARCH INSTITUTE   (United States)

^b PLLC   (United States)

^c BioTheranostics Inc   (United States)

Author keywords

Carcinoma of unknown primary (CUP); Colorectal cancer; Empirical chemotherapy; Molecular tumor profiling

Indexed keywords

ADULT; AGED; ASSAY; CANCER OF UNKNOWN PRIMARY SITE; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; FEMALE; HUMAN; MALE; METASTASIS; PREDICTION; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84860747285     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2011.08.001     Document Type: Article

References (21)

1. S. Culine, A. Lortholary, J.J. Voigt Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study - trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01) J Clin Oncol 21 2003 3479 3482 (Pubitemid 46594080)
2. F.A. Greco, N. Pavlidis Treatment for patients with unknown primary carcinoma and unfavorable prognostic factors Semin Oncol 36 2009 65 74
3. G. Huebner, H. Link, C.H. Kohne Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial Br J Cancer 100 2009 44 49
4. A. Grothey, M.M. Sugrue, D.M. Purdie Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE) J Clin Oncol 26 2008 5326 5334
5. L.B. Saltz, S. Clarke, E. Diaz-Rubio Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study J Clin Oncol 26 2008 2013 2019
6. G. Pentheroudakis, V. Golfinopoulos, N. Pavlidis Switching benchmarks in cancer of unknown primary: from autopsy to microarray Eur J Cancer 43 2007 2026 2036 (Pubitemid 47380362)
7. G. Bloom, I.V. Yang, D. Boulware Multi-platform, multi-site, microarray-based human tumor classification Am J Pathol 164 2004 9 16 (Pubitemid 38364584)
8. A.I. Su, J.B. Welsh, L.M. Sapinoso Molecular classification of human carcinomas by use of gene expression signatures Cancer Res 61 2001 7388 7393 (Pubitemid 32995021)
9. X.J. Ma, R. Patel, X. Wang Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay Arch Pathol Lab Med 130 2006 465 473
10. F.A. Monzon, F. Medeiros, M. Lyons-Weiler Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test Diagn Pathol 5 2010 3
11. E. Kaplan, P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
12. F.A. Greco, D.R. Spigel, D.A. Yardley Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction Oncologist 15 2010 500 506
13. H.M. Horlings, R.K. van Laar, J.M. Kerst Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary J Clin Oncol 26 2008 4435 4441
14. G.R. Varadhachary, T.B. Edmonston, S. Karanth Prospective gene signature study using microRNA to predict the tissue of origin (ToO) in pts with cancer of unknown primary site (CUP) J Clin Oncol 28 suppl 2010 abstract 4151 http://www.asco.org Accessed: August 29, 2011
15. G.R. Varadhachary, D. Talantov, M.N. Raber Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation J Clin Oncol 26 2008 4442 4448
16. G.R. Varadhachary, M.N. Raber, A. Matamoros Carcinoma of unknown primary with a colon-cancer profile - changing paradigm and emerging definitions Lancet Oncol 9 2008 596 599 (Pubitemid 351722584)
17. J. Bridgewater, R. van Laar, A. Floore Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary Br J Cancer 98 2008 1425 1430 (Pubitemid 351543580)
18. R.K.v. Laar, X.-J. Ma, D.D. Jong Implementation of a novel microarray-based diagnostic test for cancer of unknown primary Int J Cancer 125 2009 1390 1397
19. D. Talantov, J. Baden, T. Jatkoe A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin J Mol Diagn 8 2006 320 329 (Pubitemid 44063808)
20. R.W. Tothill, A. Kowalczyk, D. Rischin An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin Cancer Res 65 2005 4031 4040 (Pubitemid 40775639)
21. J.D. Hainsworth, D.R. Spigel, M.S. Rubin Treatment of carcinoma of unknown primary site (CUP) directed by molecular profiling diagnosis: a prospective, phase II trial J Clin Oncol (Meeting Abstracts) 28 15 suppl 2010 abstract 10540